Anti-inflammatory activity of sappanchalcone isolated from Caesalpinia sappan L. in a collagen-induced arthritis mouse model

Archives of Pharmacal Research

Volumn 38, Issue 6, 2015, Pages 973-983

  Jung, Eui Gil ^a   Han, Kook Il ^a   Kwon, Hyun Jung ^b   Patnaik, Bharat Bhusan ^c,d   Kim, Wan Jong ^a   Hur, Gang Min ^e   Nam, Kung Woo ^a   Han, Man Deuk ^a  

^a Soonchunhyang University   (South Korea)

^b Gimcheon University   (South Korea)

^c Chonnam National University   (South Korea)

^d Trident School of Biotech Sciences   (India)

^e Chungnam National University   (South Korea)

Author keywords

Arthritis score; Caesalpinia sappan L.; Collagen induced arthritis; Inflammatory cytokines; Rheumatoid arthritis; Sappanchalcone

Indexed keywords

ANTIINFLAMMATORY AGENT; CAESALPINIA SAPPAN EXTRACT; CHLOROFORM; FLAVONOID; INTERLEUKIN 1BETA; INTERLEUKIN 6; METHANOL; METHOTREXATE; SAPPANCHALCONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CHALCONE DERIVATIVE; COLLAGEN; CYTOKINE; ENZYME; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; BONE DENSITY; CAESALPINIA; CAESALPINIA SAPPAN; CONTROLLED STUDY; DBA 1 MOUSE; DISEASE SEVERITY; DRUG PURIFICATION; EXPERIMENTAL PAW EDEMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; JOINT RADIOGRAPHY; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PROTECTION; RHEUMATOID ARTHRITIS; SOLVENT EXTRACTION; TIME OF FLIGHT MASS SPECTROMETRY; ANIMAL; ARTHRITIS, EXPERIMENTAL; BONE; CHEMICALLY INDUCED; CHEMISTRY; DBA MOUSE; DRUG EFFECTS; EDEMA; FOOT; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; BONE AND BONES; BONE DENSITY; CAESALPINIA; CHALCONES; COLLAGEN; CYTOKINES; EDEMA; ENZYMES; FOOT; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED DBA; PLANT EXTRACTS;

EID: 84930930804     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-015-0557-z     Document Type: Article

References (43)

1. Agarwal, R.B., and V.D. Rangari. 2003. Anti-inflammatory and antiarthritic activities of Lupeol and 19α-H Lupeol isolated from Strobilanthus callosus and Strobilanthus ixiocephala roots. Indian Journal of Pharmacology 35: 384-387.
2. Ahmed, S., J. Anuntiyo, C.J. Malemud, and T.M. Haqqi. 2005. Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: A review. Evidence Based Complementary Alternative Medicine 2: 301-308.
3. Baek, N.I., S.G. Jeon, E.M. Ahn, J.T. Hahn, J.H. Bahn, J.S. Jang, S.W. Cho, J.K. Park, and S.Y. Choi. 2000. Anticonvulsant compounds from the wood of Caesalpinia sappan L. Archives of Pharmacol Research 23: 344-348.
4. Chamundeeswari, D., J. Vasantha, S. Gopalakrishnan, and E. Sukumar. 2003. Free radical scavenging activity of the alcoholic extract of Trewia polycarpa roots in arthritic rats. Journal of Ethnopharmacology 88: 51-56.
5. Choudhury, R.C., S.K. Ghosh, and A.K. Palo. 2000. Cytogenetic toxicity of methotrexate in mouse bone marrow. Environmental Toxicology Bulletin 8: 191-196.
6. Cohen, A., and J. Goldman. 1996. Bromelain therapy in rheumatoid arthritis. Pennsylvania Medical Journal 67: 27-30.
7. David, D.B., A.L. Kary, and F.R. Edward. 2007. Collagen-induced arthritis. Nature Protocols 2: 1269-1275.
8. Deodhar, S.D., R. Sethi, and R.C. Srimal. 1980. Preliminary studies on antirheumatic activity of curcumin. Indian Journal of Medical Research 71: 632-634.
9. Fu, L.C., X.A. Huang, Z.Y. Lai, Y.J. Hu, H.J. Liu, and X.L. Cai. 2008. A new 3-benzylchroman derivative from Sappan Ligum (Caesalpinia sappan). Molecules 28: 1923-1930.
10. Go, M.L., X. Wu, and X.L. Liu. 2005. Chalcones: An update on cytotoxic and chemoprotective properties. Current Medicinal Chemistry 12: 483-499.
11. Hosseinzadeh, H., and H.M. Younesi. 2002. Antinociceptive and anti-inflammatory effects of Crocus sativus L. stigma and petal extracts in mice. BMC Pharmacology 2: 7.
12. Hughes, S.L., D. Dunlop, P. Edelman, R.W. Chang, and R.H. Singer. 1994. Impact of joint impairment on longitudinal disability in elderly persons. Journal of Gerontology 49: 291-300.
13. Jeon, J., J.H. Lee, K.A. Park, H.S. Byun, H. Lee, Y. Lee, T. Zhang, K. Kang, J.H. Seok, H.J. Kwon, M.D. Han, S.W. Kang, J.H. Hong, and G.M. Hur. 2014. Brazilin selectively disrupts proximal IL-1 receptor signalling complex formation by targeting an IKK-upstream signalling components. Biochemical Pharmacology 89: 515-525.
14. Jeong, G.S., D.S. Lee, B. Li, H.J. Lee, E.C. Kim, and Y.C. Kim. 2011. Effects of sappanchalcone on the cytoprotection and anti-inflammation via heme oxygenase-1 in human pulp and periodontal ligament cells. European Journal of Pharmacology 644: 230-237.
15. Jung, H.W., J.K. Jung, K.H. Son, D.H. Lee, T.M. Kang, Y.S. Kim, and Y.K. Park. 2011. Inhibitory effects of the root extract of Dipsacus asper Wall on collagen-induced arthritis in mice. Journal of Ethnopharmacology 6: 98-103.
16. Kim, M.S., J.M. Yi, S.H. Kim, S.H. Hong, and H.M. Kim. 2004. Madimadi, Korean folk medicine, blocks TNF-α, IL-1β, and IL-8 production by activated human immune cells. Cytokine 25: 179-186.
17. Kumar, I.V., B.N. Paul, R. Asthana, A. Saxena, S. Mehrotra, and G. Rajan. 2003. Swertia chirata mediated modulation of interleukin-1 beta, interleukin-6, interleukin-10, interferon-gamma, and tumor necrosis factor-alpha in arthritic mice. Immunopharmacology and Immunotoxicology 25: 573-583.
18. Lee, J.D., J.E. Huh, Y.H. Baek, K.C. Cho, D.Y. Choi, and D.S. Park. 2009. The efficacy and mechanism action of RvCSd, a new herbal agent, on immune suppression and cartilage protection in a mouse model of rheumatoid arthritis. Journal of Pharmacology Sciences 109: 211-221.
19. Lee, Y.M., Y.C. Kim, B.J. Choi, D.W. Lee, J.H. Yoon, and E.C. Kim. 2011. Mechanism of sappanchalcone-induced growth inhibition and apoptosis in human oral cancer cells. Toxicology in Vitro 25: 1782-1788.
20. Liu, A.L., S.H. Shu, H.L. Qin, S.M.Y. Lee, Y.T. Wang, and G.H. Du. 2009. In vitro anti-influenza viral activities of constituents from Caesalpinia sappan. Planta Medica 75: 337-339.
21. Lubberts, E., L.A. Joosten, B. Oppers, L. van den Bersselaar, C.J. Coenen-de Roo, J.K. Kolls, P. Schwarzenberger, F.A. van de Loo, and W.B. van den Berg. 2001. IL-1 independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. Journal of Immunology 167: 1004-1013.
22. Moon, H.I., I.M. Chung, S.H. Seo, and E.Y. Kang. 2010. Protective effects of 3′-deoxy-4-O-methylsappanol from Caesalpinia sappan against glutamate-induced neurotoxicity in primary cultured rat cortical cells. Phytotherapy Research 24: 463-465.
23. Myers, L.K., E.F. Rosloniec, M.A. Cremer, and A.H. Kang. 1997. Collagen-induced arthritis, an animal model of autoimmunity. Life Sciences 61: 1861-1878.
24. Neurath, M.F., K. Hildner, C. Becker, J.F. Schlaak, K. Barbulescu, T. Germann, E. Schmitt, P. Schirmacher, S. Haralambous, M. Pasparakis, K.-H. Meyer Zum BÜschenfelde, G. Kollias, and E. MÄrker-Hermann. 1999. Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): A mechanism for methotrexate-mediated immunosuppression. Clinical and Experimental Immunology 115: 42-55.
25. Nowakowska, Z. 2007. A review of anti-infective and anti-inflammatory chalcones. European Journal of Medicinal Chemistry 42: 125-137.
26. Paul, B.N., and A.K. Saxena. 1997. Depletion of tumor-necrosis factor-alpha in mice by Nyctanthes arbor-tristis. Journal of Ethnopharmacology 56: 153-158.
27. Rathore, B., A.A. Mahdi, B.N. Paul, P.N. Saxena, and S.K. Das. 2007. Indian herbal medicines: Possible potent therapeutic agents for rheumatoid arthritis. Journal of Clinical Biochemistry and Nutrition 41: 12-17.
28. Sakaguchi, Y., H. Shirahase, A. Ichikawa, M. Kanda, Y. Nozaki, and Y. Uehara. 2004. Effects of selective iNOS inhibition on type II collagen-induced arthritis in mice. Life Sciences 75: 2257-2267.
29. Shen, J., H. Zhang, H. Lin, H. Su, D. Xing, and L. Du. 2007. Brazilein protects the brain against focal cerebral ischemia reperfusion injury correlating to inflammatory response suppression. European Journal of Pharmacology 558: 88-95.
30. Smolen, J.S., and G. Steiner. 2003. Therapeutic strategies for rheumatoid arthritis. Nature Reviews Drug Discovery 2: 473-488.
31. Smolen, J.S., K. Redlich, J. Zwerina, D. Aletaha, G. Steiner, and G. Schett. 2005. Pro-inflammatory cytokines in rheumatoid arthritis: pathogenetic and therapeutic aspects. Clinical Reviews in Allergy and Immunology 28: 239-248.
32. Stuart, J.M., M.A. Cremer, A.H. Kang, and A.S. Townes. 1979. Collagen-induced arthritis in rats: Evaluation of early immunogenic agents. Arthritis Rheumatism 22: 1344-1351.
33. Sylvester, J., A. Liacini, W.Q. Li, F. Dehnade, and M. Zafarullah. 2001. Tripterygium wilfordii Hook F extract suppresses proinflammatory cytokine induced expression of matrix metalloproteinase genes in articular chondrocytes by inhibiting activating protein-1 and nuclear factor-κB activities. Molecular Pharmacology 59: 1196-1205.
34. Szekanecz, Z., M.M. Halloran, M.V. Volin, J.M. Woods, R.M. Strieter, G.H. Kenneth, S.L. Kunkel, M.D. Burdick, and A.E. Koch. 2000. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. Arthritis Rheumatism 43: 1266-1277.
35. Tanno, K., T. Nakajima, T. Shoji, O. Nakagawasai, F. Niijima, M. Ishikawa, Y. Endo, T. Sato, S. Satoh, and T. Tadano. 2006. Anti-inflammatory effect of propolis through inhibition of nitric oxide production on carrageenan-induced mouse paw edema. Biological Pharmaceutical Bulletin 29: 96-99.
36. Ueki, Y., S. Miyake, Y. Tominaga, and K. Eguchi. 1964. Increased nitric oxide levels in patients with rheumatoid arthritis. Journal of Rheumatology 23: 230-236.
37. Van der Berg, W.B., L.A.B. Joosten, G. Kollias, and F.A.J. Van der Loo. 1999. Role of TNF-α in experimental arthritis: Separate activity of interleukin 1β in chronicity and cartilage destruction. Annals of Rheumatic Diseases 58(suppl I): 140-148.
38. Washiyama, M., Y. Sasaki, T. Hosokawa, and S. Nagumo. 2009. Anti-inflammatory constituents of Sappan Lignum. Biological and Pharmaceutical Bulletin 32: 941-944.
39. Wu, S.Q., M. Otero, F.M. Unger, M.B. Goldring, A. Phrutivorapongkul, C. Chiari, A. Kolb, H. Viernstein, and S. Toegel. 2011. Anti-inflammatory activity of an ethanolic Caesalpinia sappan extract in human chondrocytes and macrophages. Journal of Ethnopharmacology 138: 364-372.
40. Yamane, I., H. Hagino, T. Okano, M. Enokida, D. Yamasaki, and R. Teshima. 2003. Effect of minodronic acid (ONO-5920) on bone mineral density and arthritis in adult rats with collagen-induced arthritis. Arthritis and Rheumatism 48: 1732-1741.
41. Yodsaoue, O., S. Cheenpracha, C. Karalai, C. Ponglimanont, and S. Tewtrakul. 2009. Anti-allergic activity of principles from the roots and heartwood of Caesalpinia sappan on antigen-induced β-hexosaminidase release. Phytotherapy Research 23: 1028-1031.
42. Zhao, H.X., H. Bai, and Y.S. Wang. 2008. A new homoisoflavan from Caesalpinia sappan. Journal of Natural Medicine 62: 325-327.
43. Zimmerman, D.H., P. Taylor, A. Bendele, R. Carambula, Y. Duzant, V. Lowe, S.P. O'Neill, E. Talor, and K.S. Rosenthal. 2010. CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model. International Immunopharmacology 10: 412-421.